Fresenius Medical Care (NYSE:FMS) Sees Unusually-High Trading Volume – Here’s What Happened

Shares of Fresenius Medical Care AG (NYSE:FMS) saw an uptick in trading volume on Monday . 424,859 shares were traded during mid-day trading, an increase of 68% from the previous session’s volume of 252,772 shares.The stock last traded at $23.89 and had previously closed at $24.21.

Analyst Ratings Changes

A number of brokerages have recently commented on FMS. Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a report on Monday, December 2nd. Berenberg Bank assumed coverage on shares of Fresenius Medical Care in a research note on Wednesday, November 6th. They set a “buy” rating and a $25.60 price objective on the stock. StockNews.com upgraded Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th. Finally, Truist Financial increased their price target on Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Monday, January 6th.

Fresenius Medical Care Stock Performance

The company’s 50-day moving average price is $23.45 and its two-hundred day moving average price is $21.89. The company has a market cap of $13.78 billion, a P/E ratio of 19.41, a price-to-earnings-growth ratio of 0.76 and a beta of 0.93. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42.

Institutional Trading of Fresenius Medical Care

Large investors have recently added to or reduced their stakes in the business. Millennium Management LLC lifted its position in shares of Fresenius Medical Care by 5,297.5% during the 4th quarter. Millennium Management LLC now owns 722,238 shares of the company’s stock valued at $16,351,000 after acquiring an additional 708,857 shares during the last quarter. Integral Health Asset Management LLC lifted its holdings in shares of Fresenius Medical Care by 33.3% during the fourth quarter. Integral Health Asset Management LLC now owns 600,000 shares of the company’s stock valued at $13,584,000 after purchasing an additional 150,000 shares during the last quarter. Northern Trust Corp boosted its position in shares of Fresenius Medical Care by 45.9% in the 4th quarter. Northern Trust Corp now owns 362,190 shares of the company’s stock valued at $8,200,000 after purchasing an additional 113,953 shares during the period. Moran Wealth Management LLC increased its stake in Fresenius Medical Care by 9.1% in the 4th quarter. Moran Wealth Management LLC now owns 254,710 shares of the company’s stock worth $5,767,000 after purchasing an additional 21,334 shares in the last quarter. Finally, ABC Arbitrage SA acquired a new stake in Fresenius Medical Care during the 4th quarter worth about $4,215,000. 8.37% of the stock is currently owned by institutional investors.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.